期刊文献+

丙戊酸钠致凝血功能异常 被引量:1

Coagulation disorders induced by sodium valproate
原文传递
导出
摘要 1例48岁女性因继发性癫痫给予丙戊酸钠400 mg,1次/12 h静脉微泵泵入,同时给予莫西沙星、普罗帕酮、硝苯地平。第3天加用丙戊酸钠200 mg,3次/d口服。应用丙戊酸钠第1~7天患者凝血酶原时间(PT)分别为11.0、12.9、12.9、14.7、18.5、23.3、37.7(此数值为第6天第2次检查结果)、41.5 s,活化部分凝血活酶时间(APTT)分别为30.0、44.7、50.9、43.3、66.8、52.6、65.0(此数值为第6天第2次检查结果)、69.0 s,立即停用丙戊酸钠,其他3种药物继续应用。停药后2 d,PT为12.9 s,APTT为41.2 s。 A 48-year-old woman received an IV infusion of sodium valproate 400 mg every 12 hours via a pump for secondary epilepsy. Moxifloxaein, propafenone, and nifedipine were given at same time. On the third day, oral sodium valproate 200 mg thrice daily was added to the regimen. On days 1 to 7 of sodium valproate use, the prothrombin time (PT) was 11.0, 12.9, 12.9, 14.7, 18.5, 23.3, 37.7 s ( the result of the second test on day 6) , and 41.5 s, respectively. And the activated partial thromboplastin time (APTF) was 30.0, 44.7, 50.9, 43.3, 66.8, 52.6, 65.0 s ( the result of the second test on day 6) , and 69.0 s, respectively. Sodium valproate was withdrawn immediately and other three medications continued. Two days after drug discontinuation, her PT was 12.9 s and APTT was 41.2 s.
作者 吕育红 陈建
出处 《药物不良反应杂志》 2012年第1期49-50,共2页 Adverse Drug Reactions Journal
关键词 丙戊酸 凝血 valproate blood coagulation
  • 相关文献

参考文献2

二级参考文献14

  • 1李琴,贾继东,王宝恩.凝血酶原时间及凝血因子在肝病中的应用[J].中华肝脏病杂志,2004,12(12):767-768. 被引量:100
  • 2甘国胜,王庆利,吴明春,季蒙,陈利民.巴曲亭在神经外科手术中止血作用的临床研究[J].中国临床神经外科杂志,2005,10(4):257-259. 被引量:11
  • 3喻东山,李广录,汪春运.丙戊酸钠的不良反应研究新进展[J].国际神经病学神经外科学杂志,2005,32(4):319-321. 被引量:30
  • 4苏庆军,王一男,陈建国,唐茂林.纤维蛋白原的临床意义及测定[J].实用医技杂志,2006,13(23):4273-4274. 被引量:27
  • 5Gerstner T, Busing D, Bell N, et al. Valproic acid-induced pancreatitis: 16 new cases and a review of the literature [ J ]. J Gastroenterol, 2007, 42 ( 1 ) : 39-48.
  • 6Serdaroglu G, Ttittincuoglu S, Kavakli K, et al. Coagulation abnormalities and acquired von willebrand's diseases type 1 in children receiving valproic acid [ J ]. J Child Neurol, 2002, 17(1): 41-43.
  • 7Tong V, Teng XW, Chang TK, et al. Valproic acid Ⅰ: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats[ J]. Toxicol Sci, 2005, 86(2):427-435.
  • 8Meltem U, Cengiz Y. Protein C, protein S and other proand anticoagulant activities among epileptic children using sodium valproate [ J ]. Brain Dev, 2006, 28 ( 9 ) : 549- 553.
  • 9Weller EB, Danielyan AK, Weller RA. Somatic treatment of bipolar disorder in children and adolescents [ J 1- Psyehiatr Clin North Am, 2004, 27(1) :155-178.
  • 10Harden CL. Theraputie safty monitoring: what to look for and when to look for it[J]. Epilepsia, 2000, 41 (Suppl 8) : S37-44.

共引文献17

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部